This paper presents a predictive accuracy comparison between the Multivariate Logistic Regression (MLR) and the Bayesian Neural Network (BNN). The lat,ter is presented in this paper as an alternative to the MLR (MLR). The M LR and BNN have been used to ident,ify early breast cancer patients wit,h high risk of tumour recurrence at the time of initial resection.
Introduction
Several issues have been raised by stat,isticians and medical personnel in relation to the application of the standard Multilayer Perceptron to the analyss of medical data. The problem lies in the application of the Artificial Neural Net,worlts issues such as the which input. ant ancl t,he correct, number of layers ancl the nnmber of units in each layer in order to obtain a certain level of performance.
To resolve the problem of select,ing t,he optimum design choices for t.he MLP! we applied Bayes' Theorem: which embodies the philosophy of William Occam, to provide a framework for selecting the optimum ANN architecture. The archit,ect,ure i s opt,imal in the sense that preference is given to the simplest* model (least, number of layers and units) which adequately models the training data. Model comparison can he done by evaluating a quantitative value t,ermed the evidence. The evidence calcolated for each ANN model t,alies into consideration the goodness of fit and the complexity of the model. The principle penalises complex models and favours "l'his research was supporbed by lhe Caricsr f'oundation uC Weslerri Australia.
the simplest model. Using the Bayesian Neural Network (BNN), we were able to address some of the drawbacks of t8he standard MLP.
Bayesian methods for induct,ive inference were developed in det,ail by a Cambridge geophysicist., Sir Harold Jefferys [5] . Bayes' theorem is regarded as n form of common sense reasoning, providing the framework to manipulate probability distributions. But, t,o apply Bayesian reasoning, firstly we need to transform the medical information into a numerical probability distribution using some other principle. This can be achieved using the standard statistical models such as the Multivariate Logistic Regression (MLR) or ANNs. Bayes' framework can also be used to determine the significance of each individual risk factor to the outcome. The framework, t,ermed Azrtomcitzr Relevuace Determncrtion (ARD), is due to published works of MacKay in lY9l -1992 [6, 7, 81: Gull [3; 41. About 7000 Australian womens are diagnosed with early breast cancer annually [2] . In many of these patients! breast cancer is a systemic disease at diagnosis and is therefore not curable hy surgical removal of t,he primary t,nmour alone. Breast cancer i s a heterogeneous disease; resnlting in a wide range of treat,ment options. These treatments vary widely in toxicit,y, from relatively harmless (such as hmoxifen) to highly aggressive experimental therapy (such as bone narrow transplantation). Decisions about which patients to t,reat with these different, forins of adjuvant, therapies require that. we confront, two important issues. Firstly, what i s an accept,ahle risk of recurrence, that, is; a risk so low as to argue against the need for systemic therapy. iiccurate assessment of t,he probability of recurrence i s therefore essential in deciding the appropri-0-7803-41 37-6/97/$10.00@1977 IEEE DSP 97 -83 ate adjuvant treatment for individual patients [I] . Secondly, the question arises a s to whether we have the prognostic factors to predict. the risk of reciirrenre with a high degree of accuracy. This paper focuses on the question of how we can best identify node positive patients who will have a high or low probability of recurrence at t.he early stage of the disease. We invest,igated the use of four risk factors previously analysed using statistical methods by Seshadri and associates [9] 
Bayesian Iiifereiice of t h e weight parameters (Level I)
Bayesian analysis involves using the out,put of the network, g(x) t*o construct, the likelihood function! P ( y I xlw) for t,he training data D = (x!y). We wwit to train t,he BNN netmork to give ns the most probahle weight parameter, w,lfpi given the data (x; y ) : network configuration ( M i ) and some scaling parameters which will be discussed lat,er in t,his chapter. Using Bayes' rule, the posterior probability of the weight parameter is;
where P(w I %,Mi) is the post,erior probability of the ANN weight parameters, w .
Infering the most. probable weight,s involves: 
w , M , )
e ANN training procedure is used to find a of weights that maxiiniSes the likelihood of 
The ultiinak goal in the modelling process is ( 3 ) to be able to predict the outcome for iiew patients based on the information cont,ained in a where I'(P I N ; 8, .,U;) is t,lie norsnalisat,ioii coilstant and o is the regularising term.
2.1.2
The oiily consistent, prior for t,he weight parametmer, w is of t,he Gaussian form:
Prior probability of the wcights where Z<,(YY) = I m p ( -n E~v ) & d and Ew =
Substitut,ing equations (5) and (7) (10) 3 Breast Cancer Prognosis
111)
The data set used in this investigat,ion relates t80 351 women in South Aust,ralia and Western A u stralia diagnosed with breast carcinoma between 1987 and 1992. For all pat,ients, t,heir diagnosis was confirmed by biopsy and treated either by total (75% of patient.s) or partncd (26% of pat,ient#s) mastectomy. All pat,ient,s had had axillary lymph node clearance wit8h posit,ive confirmation of met,astases therein. The four criteria for inclusion in t,his st,udy are:
Only node posit,ive pat,ients are considered.
Patients wit,h stage-IV disease or for whom axillary clearance was not performed were excluded.
Patients without, recurrence are required t,o have a niinimi.iiii follow-up period of 18 months.
Information on all t,he risk factors considered is available.
This study concentrat,es only on t,he significant, predictive property of risk factors to predict local or distant recurrence for the node positive patient within eighteen mont,hs after diagnosis. We have noted in t,he earlier sect,ions t,hat the A consecutive series of 351 node-positive pa-BNN network is an integration of the Multilayer tients with complet,e axillary dissection were avail-Perceptron and Bayes Theorem. Using t,he BNN able for this case st,udy. Detailed descriptions regarding the preparation of breast sample for hormone receptor and Cat.hepsin-D amlysis have been given in [9] .
Risk Factors
Hist,opathological features considered in this case study are similar to the study conduct,ed by Seshadri [9] .In this study, apart from analysing the prognostic values of the respective risk factors, considera.tion was also given to predict,ing the risk of relapse for individual patient,% The risk fa.ctors used in the study are Tumour Size (TS)! Niiinber of Nodes, Estrogen Receptor (ER) and
Cat!hepsin-D (Cath-D).
The breast carcinoma data were analysed 11s-ing both the Bayesian Neural Network (BNN) and the Multivariate Logist.ic Regression (h4LR) methods. Patients were assigned randoinly ancl independently from the dat,a set to a t,raining set used to construct. t,he model and a t,esting set, 
MLR, Bayesian MLR and BNN inodel
For the const,ruction of the Standa.rd 1\KR models; the standard multivariat,e logistic regression method was applied. The Bayesian h4LR model was constructed using the BNN net.work with no hidden nodes a.ncl one output node with sigmoidal activa.tion function. 'This BNN network was trained to maximise the likelihood of the t,raining data. This is similar in principle t,o t,he multivariate 1ogist.ic finiction, except, in t.his case, regulariser terms are attached to each input. The parametric function of t,his BNN model is equivalent to t,he standard h4LR model.
In the case of the BNN modeli one hidden layer was used in the modelling process. The sigmoidal a h v a t i o n fiinct,ion was applied to all t8he units wit,h the exception of the input, units. 
Forced Classification Accuracy
Patient,s were stratified into two risk groups, M-+ and M-. Table 2 tabulates t.he predicted status of individual pat,ients. 'The BNN has higher predictive accuracy for both NI+ and M-patients in comparison to the MLR and t,he Bayesian MILR model.
Discussion
The analyses carried out, in this case st,udy concentmtes on two things. Firstaly, can we predict t.he probability of recurrence for t,he nodeposit,ive patient on the basis of information about tumour characteristics. Srcondly, to compare t,he predictive accuracy of t,he MLR and BNN network since the use of tlie BNN net,work is a novel approach in this area. The MLR) Bayesian MILR and BNN models were const,ruct,ed using 184 patients (training dat,a) and the remaining 167 patients were used tso assess their predictive quality.
The BNN embodies t,he Occam principle and Bayes Theorem to provide a qnaiit,it8at,ive assessment for ranking alternat,ive ANN models. lrsing t,he evidence framework. a BNN network -can also determine which risk factors are correlat,ed to the prediction of recurrence. This knowledge has previously been embedded in the distributed weights of the bILP model. TJsing a regulariser term ( a ) for each input., the N associated with irrelevant inputs will be given large values to prevent these inpiits from affect,ing the resulting predict,ion. In the multinomial model: only two variables were found to be st,at,istsically significant independent predictors. They are number of nodes involved ( N = 0.029) and the ER concentration ( a = 0.016). The same two variables were also found to be stlatist8ically significant in the MLR model, P = 0.02 and P = 0,007, respectively. Both the BNN and the MLR models found the risk fact,ors tumour size and Cathepsin-D to be uncorrelated to prediction of recurrence. Note that t,he prognost,ic significance of ER may be due t,o its relationship with response t,o tamoxifen administered to some patients.
he MLR and the BNN models were also t,ested on 167 patient,s not iised t.o construct the model to assess their predict,ive quality. The BNN net,-work predictbed more accurately for bot,h MET+ patient,s (70.0%) and the MET-pat,ients (61.3%). In comparison: the MLR predictmion accuracy was 57.6% and 66.7% for MET-and MET+ respectively. The higher percentage of patients correctly classified as having MET+ indicates t,hat t8he adjuvant t,herapy selected for individual patients only prolongs the disease free recurrence for 38.7% of the MET-patients. The analysis carried out considered only four risk fact.ors to predict the prohahilit-y of relapse and was restricted to patients who had had some form of ad.jnvant therapy.
In view of the small sample size! further verification of the BNN model is required before it can he applied t,o assess the probability of recurrence in larger populat,ions.
Conclusion
The novel analysis using the Bayesian Neural Network has been shown t.o eliniinate soine of the drawbacks of the standard MLP ndwork.
The evidence framework and t,he aut.omatic rel-evance determination provide ways t,o determine the optimum network size plus ident,ifying inputs which are independeiit, predictors of the outcome. The BNN model mas more acc1irat.e (higher liltelihood) and achieved higher predict,ive, value in compa.rison to the multivariate logistic regression models. This case st,udy concentratmecl on assessing the risk of recurrence for node positive patients for Tvhom some form of adjuvant therapy has been given. The same modelling procedure can he used to assess the risk of recurrence for node negative pat.ients or for iiode positive pat.ient.s for whom acljuvant, therapy have not. been administ,ered. This modelling process will enable clinicians to assess the risk of recurrence given the information about, tumour characterist,ics and t.0 select. appropria.te treat.ment for both high risk node negative pat,ients and node positive patienk.
